Search Results - "Goldberg, D.S."

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Improving Organ Utilization to Help Overcome the Tragedies of the Opioid Epidemic by Goldberg, D. S., Blumberg, E., McCauley, M., Abt, P., Levine, M.

    Published in American journal of transplantation (01-10-2016)
    “…Death rates from drug overdoses have nearly doubled since 2003, with over 47 000 deaths in 2014. This is largely attributable to the opioid epidemic. If the…”
    Get full text
    Journal Article
  8. 8

    Sociodemographic Determinants of Waitlist and Posttransplant Survival Among End‐Stage Liver Disease Patients by Ross, K., Patzer, R. E., Goldberg, D. S., Lynch, R. J.

    Published in American journal of transplantation (01-11-2017)
    “…While regional organ availability dominates discussions of distribution policy, community‐level disparities remain poorly understood. We studied…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Increasing the Number of Organ Transplants in the United States by Optimizing Donor Authorization Rates by Goldberg, D. S., French, B., Abt, P. L., Gilroy, R. K.

    Published in American journal of transplantation (01-08-2015)
    “…While recent policies have focused on allocating organs to patients most in need and lessening geographic disparities, the only mechanism to increase the…”
    Get full text
    Journal Article
  11. 11

    Maximizing Utilization of the Donor Pool by Appropriate Classification of Hepatitis C Antibody‐Positive Donors by Anesi, J. A., Goldberg, D. S.

    Published in American journal of transplantation (01-11-2017)
    “…Nucleic acid testing for hepatitis C virus among deceased donors can more accurately determine whether a donor is actively infected than serology testing, and…”
    Get full text
    Journal Article
  12. 12

    Use of Population‐based Data to Demonstrate How Waitlist‐based Metrics Overestimate Geographic Disparities in Access to Liver Transplant Care by Goldberg, D. S., French, B., Sahota, G., Wallace, A. E., Lewis, J. D., Halpern, S. D.

    Published in American journal of transplantation (01-10-2016)
    “…Liver allocation policies are evaluated by how they impact waitlisted patients, without considering broader outcomes for all patients with end‐stage liver…”
    Get full text
    Journal Article
  13. 13

    Retransplantation After a Failed Donation After Circulatory Determination of Death Liver Transplant: MELD Exception Priority and Second Chances by Abt, P. L., Goldberg, D. S.

    Published in American journal of transplantation (01-09-2017)
    “…A standardized exception score that allows access for retransplantation in the setting of graft failure due to ischemic cholangiopathy with donation after…”
    Get full text
    Journal Article
  14. 14

    MELD Exceptions for Portopulmonary Hypertension: Current Policy and Future Implementation by Goldberg, D. S., Batra, S., Sahay, S., Kawut, S. M., Fallon, M. B.

    Published in American journal of transplantation (01-09-2014)
    “…Since 2006, waitlist candidates with portopulmonary hypertension (POPH) have been eligible for standardized Model for End‐Stage Liver Disease (MELD) exception…”
    Get full text
    Journal Article
  15. 15

    Kidney allograft offers: Predictors of turndown and the impact of late organ acceptance on allograft survival by Cohen, J. B., Shults, J., Goldberg, D. S., Abt, P. L., Sawinski, D. L., Reese, P. P.

    Published in American journal of transplantation (01-02-2018)
    “…There is growing interest in understanding patterns of organ acceptance and reducing discard. Little is known about how donor factors, timing of procurement,…”
    Get full text
    Journal Article
  16. 16

    Sustained Posttransplantation Diabetes Is Associated With Long‐Term Major Cardiovascular Events Following Liver Transplantation by Roccaro, G. A., Goldberg, D. S., Hwang, W.‐T., Judy, R., Thomasson, A., Kimmel, S. E., Forde, K. A., Lewis, J. D., Yang, Y.‐X.

    Published in American journal of transplantation (01-01-2018)
    “…Cardiovascular disease is a leading cause of death among liver transplant (LT) recipients. With a rising burden of posttransplantation metabolic disease,…”
    Get full text
    Journal Article
  17. 17

    Healthcare utilization after liver transplantation is highly variable among both centers and recipients by Bittermann, T., Hubbard, R. A., Serper, M., Lewis, J. D., Hohmann, S. F., VanWagner, L. B., Goldberg, D. S.

    Published in American journal of transplantation (01-05-2018)
    “…The relationship between healthcare utilization before and after liver transplantation (LT), and its association with center characteristics, is incompletely…”
    Get full text
    Journal Article
  18. 18

    Evidence for dynamically organized modularity in the yeast protein-protein interaction network by Han, J.D.J, Bertin, N, Hao, T, Goldberg, D.S, Berriz, G.F, Zhang, L.V, Dupuy, D, Walhout, A.J.M, Cusick, M.E, Roth, F.P

    Published in Nature (01-07-2004)
    “…In apparently scale-free protein-protein interaction networks, or 'interactome' networks, most proteins interact with few partners, whereas a small but…”
    Get full text
    Journal Article
  19. 19

    Improving Outcomes in DCDD Liver Transplantation: There Can Only Be Strength in Numbers by Goldberg, D. S., Abt, P. L.

    Published in American journal of transplantation (01-05-2014)
    “…In the United States, liver transplantation using donation after circulatory determination of death (DCDD) donors is challenged by persistently inferior graft…”
    Get full text
    Journal Article
  20. 20

    An Assessment of HIV‐Infected Patients Dying in Care for Deceased Organ Donation in a United States Urban Center by Richterman, A., Sawinski, D., Reese, P. P., Lee, D. H., Clauss, H., Hasz, R. D., Thomasson, A., Goldberg, D. S., Abt, P. L., Forde, K. A., Bloom, R. D., Doll, S. L., Brady, K. A., Blumberg, E. A.

    Published in American journal of transplantation (01-08-2015)
    “…Organ transplantation is an acceptable option for human immunodeficiency virus (HIV)‐infected patients with end‐stage kidney or liver disease. With worse…”
    Get full text
    Journal Article